BioCentury | Jan 20, 2014
Company News

Elixir Medical sales and marketing update

...Elixir launched its DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System in Europe to treat coronary artery disease (CAD). The scaffold is available...
BioCentury | May 20, 2013
Clinical News

DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System regulatory update

...Elixir received CE Mark approval for its DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System to treat coronary artery disease (CAD). Elixir plans...
...lactide (PLLA)-based polymer coronary scaffold that delivers novolimus. Elixir Medical Corp. , Sunnyvale, Calif. Product: DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System...
Items per page:
1 - 2 of 2